Skip to main content
. 2022 Nov 29;8(12):2552–2563. doi: 10.1021/acsinfecdis.2c00445

Table 4. MIC of MGB-BP-3 and Vancomycin against S. aureus ATCC 43300 in the Presence of 1 μg/mL E. coli LPS.

  S. aureus ATCC 43300 MIC80 (μM)
condition MGB-BP-3 vancomycin
drug only 0.1 0.2
drug and LPS 0.8 0.2
fold-increase 8 1